The EtOAcAP showed the strongest antitumor activity on bladder cancer cell lines (IC50 = 21.33–25.28 μg/mL), compared to the EtOAcR extract, by inducing apoptosis and inhibiting NFkB p65 [32]. Here, NFKB1 is linked to urinary bladder carcinoma.